drugset / Trial / NCT02396030

Different Schemes of Magnesium Sulfate for Preeclampsia

NCT02396030

RandomizedParallel-groupTriple-blindPrevention

Summary

Eclampsia is an obstetric emergency capable of prophylaxis. To prevent and control seizures, there is no doubt that the magnesium sulfate (MgSO4) is the ideal drug. However, there are still questions regarding its use and dose. The scheme and the optimal time of administration remain to be elucidated. The objective of this trial is to compare the effectiveness and safety of intravenous magnesium sulfate in the maintenance phase 1g / h versus 2 g / h to prevent eclampsia in pregnant and postpartum women with severe preeclampsia (pure or superimposed).

Timeline

Start
2015-03
Primary completion
2016-03
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 1 g Intravenous
Comparator Magnesium Sulfate Other / unclassified 2 g Intravenous

Indications